Antihyperlipidemic and Antioxidant Effects of Averrhoa Carambola Extract in High-Fat Diet-Fed Rats

• Published in: Biomedicines Vol. 7; no. 3; p. 72
• Main Authors: Aladaileh, Saleem, Saghir, Sultan, Murugesu, Kisantini, Sadikun, Amirin, Ahmad, Ashfaq, Kaur, Gurjeet, Mahmoud, Ayman, Murugaiyah, Vikneswaran
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 16.09.2019; MDPI
• Subjects: Accuracy; Acids; Antioxidants; Averrhoa carambola; Bile acids; Body mass index; Body weight; Calibration; Cardiovascular disease; Cholesterol; Dietary supplements; Dosage; dyslipidemia; Food intake; High fat diet; HMG-CoA; Hydroxymethylglutaryl-CoA reductase; Hyperlipidemia; Lipase; Lipid peroxidation; Lipids; Liver; Oral administration; Oxidative stress; Pancreas; Serum lipids; Signal to noise ratio; Solvents; Standard deviation; Standardization; Triglycerides; United States > US; Penang Malaysia; Malaysia
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines7030072

The present study explored the antihyperlipidemic potential of a standardized methanolic extract of Averrhoa carambola (A. carambola) leaf (MEACL) in high-fat diet (HFD)-fed rats. The standardized MEACL was orally administered at different doses (250, 500, and 1000 mg/kg) to HFD-induced hyperlipidemic rats for five weeks. Serum lipid profile, body weight changes, body mass index (BMI), daily food intake, relative organ weight, and histology of the liver were evaluated. In addition, the effect of MEACL on HMG-CoA reductase and pancreatic lipase activities as well as hepatic and fecal lipids was demonstrated. MEACL supplementation reduced serum lipids in HFD-fed rats in a dose-dependent manner. Histopathological scores revealed that 1000 mg/kg MEACL restored the damage to liver tissue in hyperlipidemic rats. MEACL decreased the body mass index (BMI), atherogenic index, and hepatic cholesterol and triglycerides and increased fecal cholesterol and bile acids in HFD-fed rats. Also, MEACL ameliorated lipid peroxidation and improved antioxidant defenses in the liver of HFD-fed rats. Furthermore, HMG-CoA reductase and lipase were suppressed by MEACL. In conclusion, this study shows the potential effect of MEACL to ameliorate hyperlipidemia and oxidative stress in HFD-fed rats. It prevented hepatic lipid accumulation and exerted an inhibitory effect on HMG-CoA reductase and lipase.